Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker DOCS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 10,721 | $35.00 | $375.2K Sale | Form 4 ↗ |
| Nov 2, 2026 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $32.89 | $65.8K Sale | Form 4 ↗ |
| Oct 14, 2026 | Siddharth Sitaram Chief Accounting Officer | DOCS Doximity, Inc. | Sale | 2,613 | $30.68 | $80.2K Sale | Form 4 ↗ |
| Sep 15, 2026 | Siddharth Sitaram Chief Accounting Officer | DOCS Doximity, Inc. | Sale | 2,077 | $26.02 | $54.0K Sale | Form 4 ↗ |
| Sep 1, 2026 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $26.33 | $52.7K Sale | Form 4 ↗ |
| Aug 25, 2026 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $24.95 | $49.9K Sale | Form 4 ↗ |
| Aug 13, 2026 | Siddharth Sitaram Chief Accounting Officer | DOCS Doximity, Inc. | Sale | 1,770 | $24.94 | $44.1K Sale | Form 4 ↗ |
| Aug 7, 2026 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 7,500 | $39.11 | $293.3K Sale | Form 4 ↗ |
| Jul 15, 2026 | Siddharth Sitaram Chief Accounting Officer | DOCS Doximity, Inc. | Sale | 1,732 | $22.02 | $38.1K Sale | Form 4 ↗ |
| Jun 8, 2026 | Siddharth Sitaram Interim PAO | DOCS Doximity, Inc. | Sale | 2,444 | $20.41 | $49.9K Sale | Form 4 ↗ |
| May 11, 2026 | Siddharth Sitaram Interim PFO and PAO | DOCS Doximity, Inc. | Sale | 2,309 | $25.77 | $59.5K Sale | Form 4 ↗ |
| May 7, 2026 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 9,000 | $26.06 | $234.5K Sale | Form 4 ↗ |
| Apr 10, 2026 | Siddharth Sitaram Interim PFO and PAO | DOCS Doximity, Inc. | Sale | 2,427 | $21.09 | $51.2K Sale | Form 4 ↗ |
| Mar 10, 2026 | Siddharth Sitaram Interim PFO and PAO | DOCS Doximity, Inc. | Sale | 2,319 | $25.37 | $58.8K Sale | Form 4 ↗ |
| Mar 3, 2026 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $26.00 | $52.0K Sale | Form 4 ↗ |
| Feb 10, 2026 | Siddharth Sitaram Interim PFO and PAO | DOCS Doximity, Inc. | Sale | 2,282 | $27.88 | $63.6K Sale | Form 4 ↗ |
| Feb 2, 2026 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $37.33 | $74.7K Sale | Form 4 ↗ |
| Jan 2, 2026 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $44.65 | $89.3K Sale | Form 4 ↗ |
| Dec 1, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $50.71 | $101.4K Sale | Form 4 ↗ |
| Nov 21, 2025 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 10,000 | $50.00 | $500.0K Sale | Form 4 ↗ |
| Nov 3, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $66.44 | $132.9K Sale | Form 4 ↗ |
| Oct 10, 2025 | Regina M. Benjamin Director | DOCS Doximity, Inc. | Sale | 5,000 | $70.84 | $354.2K Sale | Form 4 ↗ |
| Oct 1, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $70.01 | $140.0K Sale | Form 4 ↗ |
| Sep 24, 2025 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 20,000 | $75.00 | $1.5M Sale | Form 4 ↗ |
| Sep 12, 2025 | Regina M. Benjamin Director | DOCS Doximity, Inc. | Sale | 5,000 | $70.50 | $352.5K Sale | Form 4 ↗ |
| Sep 2, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $66.57 | $133.1K Sale | Form 4 ↗ |
| Sep 2, 2025 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 6,360 | $66.30 | $421.7K Sale | Form 4 ↗ |
| Aug 26, 2025 | Anna Bryson Chief Financial Officer | DOCS Doximity, Inc. | Sale | 40,000 | $66.76 | $2.7M Sale | Form 4 ↗ |
| Aug 15, 2025 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 3,800 | $64.19 | $243.9K Sale | Form 4 ↗ |
| Aug 15, 2025 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 16,200 | $63.68 | $1.0M Sale | Form 4 ↗ |
| Aug 8, 2025 | Regina M. Benjamin Director | DOCS Doximity, Inc. | Sale | 5,000 | $63.00 | $315.0K Sale | Form 4 ↗ |
| Aug 1, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $57.09 | $114.2K Sale | Form 4 ↗ |
| Jul 11, 2025 | Regina M. Benjamin Director | DOCS Doximity, Inc. | Sale | 5,000 | $60.04 | $300.2K Sale | Form 4 ↗ |
| Jul 1, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $60.96 | $121.9K Sale | Form 4 ↗ |
| Jun 25, 2025 | Regina M. Benjamin Director | DOCS Doximity, Inc. | Sale | 10,000 | $60.00 | $600.0K Sale | Form 4 ↗ |
| Jun 25, 2025 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 10,000 | $60.00 | $600.0K Sale | Form 4 ↗ |
| Jun 2, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $52.89 | $105.8K Sale | Form 4 ↗ |
| May 23, 2025 | Timothy S. Cabral Director | DOCS Doximity, Inc. | Sale | 10,000 | $50.58 | $505.8K Sale | Form 4 ↗ |
| May 2, 2025 | Anna Bryson Chief Financial Officer | DOCS Doximity, Inc. | Sale | 50,000 | $60.00 | $3.0M Sale | Form 4 ↗ |
| May 1, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 411 | $57.64 | $23.7K Sale | Form 4 ↗ |
| May 1, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 1,589 | $56.74 | $90.2K Sale | Form 4 ↗ |
| May 1, 2025 | Anna Bryson Chief Financial Officer | DOCS Doximity, Inc. | Sale | 22,759 | $57.65 | $1.3M Sale | Form 4 ↗ |
| May 1, 2025 | Anna Bryson Chief Financial Officer | DOCS Doximity, Inc. | Sale | 22,241 | $56.80 | $1.3M Sale | Form 4 ↗ |
| Apr 1, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 814 | $58.31 | $47.5K Sale | Form 4 ↗ |
| Apr 1, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 6,186 | $57.63 | $356.5K Sale | Form 4 ↗ |
| Mar 3, 2025 | Kira Scherer Wampler Director | DOCS Doximity, Inc. | Sale | 2,000 | $70.89 | $141.8K Sale | Form 4 ↗ |
| Feb 12, 2025 | Watkin Phoebe L. Yang Director | DOCS Doximity, Inc. | Sale | 2,889 | $75.19 | $217.2K Sale | Form 4 ↗ |
| Feb 12, 2025 | Tangney Schweikert Family Trust 10% owner | DOCS Doximity, Inc. | Sale | 13,052 | $75.83 | $989.7K Sale | Form 4 ↗ |
| Feb 12, 2025 | Tangney Schweikert Family Trust 10% owner | DOCS Doximity, Inc. | Sale | 474,448 | $75.33 | $35.7M Sale | Form 4 ↗ |
| Feb 12, 2025 | Tangney Schweikert Family Trust 10% owner | DOCS Doximity, Inc. | Sale | 27,433 | $75.33 | $2.1M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 4:23 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances